Further progress in the treatment of multiple myeloma.
dc.contributor.author | Malik, Prabhat Singh | |
dc.contributor.author | Kumar, Lalit | |
dc.date.accessioned | 2012-06-15T09:19:43Z | |
dc.date.available | 2012-06-15T09:19:43Z | |
dc.date.issued | 2009-01 | |
dc.identifier.citation | Malik Prabhat Singh, Kumar Lalit. Further progress in the treatment of multiple myeloma. National Medical Journal of India. 2009 Jan-Feb; 22(1): 25-27. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/139035 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.nmji.in/archives/Volume-22/Issue-1/PDF-volume-22-issue-1/Volume-22-issue-1-Select-Sumry3.pdf | en_US |
dc.subject.mesh | Antineoplastic Agents --therapeutic use | |
dc.subject.mesh | Antineoplastic Agents, Alkylating --therapeutic use | |
dc.subject.mesh | Antineoplastic Agents, Hormonal --therapeutic use | |
dc.subject.mesh | Boronic Acids --therapeutic use | |
dc.subject.mesh | Humans | |
dc.subject.mesh | India | |
dc.subject.mesh | Melphalan --therapeutic use | |
dc.subject.mesh | Multiple Myeloma --drug therapy | |
dc.subject.mesh | Multiple Myeloma --mortality | |
dc.subject.mesh | Prednisone --therapeutic use | |
dc.subject.mesh | Pyrazines --therapeutic use | |
dc.title | Further progress in the treatment of multiple myeloma. | en_US |
dc.type | Article | en_US |